Evidence map›Paper›PMID 35473576›Full record

ArticleSubstance abuse treatment, prevention, and policy2022

Knowledge and experience of Kazakhstan athletes in anti-doping and the impact of past educational intervention.

Galiya Zhumabayeva, Gulnara Kapanova, Denis Vinnikov, Maira Bakasheva, Venera Abdulla, Andrej Grjibovski

Open access · goldAbstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Galiya ZhumabayevaAl-Farabi Kazakh National University, Almaty, Kazakhstan. gzhymabayeva@gmail.com.
Gulnara KapanovaAl-Farabi Kazakh National University, Almaty, Kazakhstan.
Denis VinnikovAl-Farabi Kazakh National University, Almaty, Kazakhstan.
Maira BakashevaKazakhstan National Anti-Doping Center, Almaty, Kazakhstan.
Venera AbdullaKazakhstan Medical University "Higher School of Public Health", Almaty, Kazakhstan.
Andrej GrjibovskiAl-Farabi Kazakh National University, Almaty, Kazakhstan.
Al-Farabi Kazakh National University · KZKazakhstan Medical University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough Kazakhstan National Anti-Doping Organization (KazNADO) exists since 2013, but little is yet known about anti-doping (AD) knowledge of Kazakhstan athletes. The aim of this study was to assess the AD education knowledge level and experience among Kazakhstan athletes, as well as the impact of any past AD educational program on them.

methodsAltogether, 590 athletes (the median was age 17 years (interquartile range 8)), representing various sports, participated in the web-based study and completed the questionnaire, which consisted of socio-demographic part and ALPHA test. We assessed the association of any past AD education and experience with anti-doping knowledge using adjusted regression models.

resultsA total of 54.6% participants underwent doping control and 82,7% of athletes received AD education at least once. More than 300 participants (50.8%) provided correct answers for 10 questions. Age and years in sports (competition duration) were significantly associated with the ALPHA scores of athletes. Athletes who received AD education more than once in the past had significantly higher ALPHA scores than non-AD educated athletes in most questions.

conclusionAD education was associated with AD knowledge. Further research is needed to identify the adherence to anti-doping knowledge.

Indexed as

Doping in SportsAdolescentAthletesHealth Knowledge, Attitudes, PracticeHumansKazakhstanSurveys and QuestionnairesALPHA testAnti-doping educationDopingKazakhstanWADA

Identifiers

PMID35473576
PMCPMC9040359
OpenAlexW4224436852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.